Sabine Kreinecker-Spiegl
Linz, 4040, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2026
Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges.
Journal: Cancer treatment reviews
Published: November 17, 2025
Tumor-suppressive role of miR-216b impacts cell cycle regulation in high-grade glioma.
Journal: Acta neuropathologica communications
Published: September 29, 2025
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment Strategies.
Journal: Neuro-oncology
Published: June 02, 2025
Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies.
Journal: Neuro-oncology
Published: June 02, 2025
Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT).
Journal: Neuro-oncology advances
Published: May 12, 2025
Association of Intergenic and Intragenic MGMT Enhancer Methylation with MGMT Promoter Methylation, MGMT Protein Expression and Clinical and Demographic Parameters in Glioblastoma.
Journal: International journal of molecular sciences
Published: March 01, 2025
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.
Journal: Neuro-oncology
Published: November 18, 2024
Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling.
Journal: Cell reports. Medicine
Published: November 28, 2023
Association of MGMT Promoter and Enhancer Methylation with Genetic Variants, Clinical Parameters, and Demographic Characteristics in Glioblastoma.
Journal: Cancers
Published: November 03, 2023
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma.
Journal: Cells
Published: May 18, 2023
Last Updated: 09/26/2026